Blood glucose-lowering drugs, such as metformin and SGLT2 inhibitors, reduced the risk of diabetic cardiovascular death, kidney disease, and heart failure by upregulating autophagy [40]. The gene discussed is SLC5A2; the disease is kidney disorder.